News

DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript

9 Mins read

DBV Technologies S.A. (NASDAQ:DBVT) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ET

Company Participants

Katie Matthews – Head of Investor Relations

Daniel Tassé – Chief Executive Officer

Pharis Mohideen – Chief Medical Officer

Conference Call Participants

Rajan Sharma – Goldman Sachs

Operator

Welcome to the DBV’s Third Quarter Financial Results and Business and Regulatory Update Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Katie Matthews, Investor Relations. Please go ahead.

Katie Matthews

Thank you. This afternoon, DBV Technologies issued a press release that outlines our financial results for the 9 months ended September 30, 2023. This press release is available in the Press Releases section of the DBV Technologies’ website.

Before we begin, please note that today’s call may include a number of forward-looking statements, including but not limited to, comments regarding our clinical and regulatory development plans, the design of our anticipated clinical trials, the timing and results of interactions with regulatory agencies, our forecast of our cash runway and the ability of any of our product candidates, if approved, to improve the lives of patients with food allergies. These forward-looking statements are based on assumptions that are subject to risks and uncertainties that could cause the company’s actual results to differ significantly from those suggested by these statements. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Please refer to the company’s filings with the SEC and the French AMF for information concerning risk factors that could cause the company’s actual results to differ materially from expectations, including any forward-looking statements made on this call. Except as required by law, the company disclaims any obligation to publicly update or revise any forward-looking statements to account for or reflect events or circumstances that occur after this call.

Read the full article here

Related posts
News

Jackson Financial: An Undervalued Small Cap With Upside Potential (NYSE:JXN)

2 Mins read
This article was written by Follow Mr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on…
News

Behavioral Biases Worsen Super Micro Computer Stock's Sentiment (NASDAQ:SMCI)

2 Mins read
This article was written by Follow Pythia Research offers a unique perspective by combining a deep social sciences and psychology background with…
News

Rexford: Debt Metrics, Pricing Power, Pessimistic Valuation Make It Undeniable (REXR)

2 Mins read
This article was written by Follow I only buy strong businesses. I only buy them when they’re cheap. Backgrounds in economics, philosophy,…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *